BackFrazier Lifesciences Acquisition Overview

Frazier Lifesciences Acquisition Long Term Debt

Frazier Lifesciences Acquisition's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Frazier Lifesciences Acquisition Long Term Debt History

Loading

Frazier Lifesciences Acquisition vs. peers: Long Term Debt Comparison

Loading

Frazier Lifesciences Acquisition Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Frazier Lifesciences Acquisition (FLAC) FAQ

As of the most recent data (September 2022), FLAC shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FLAC's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Frazier Lifesciences Acquisition is outperforming or lagging.

Tracking FLAC's long-term debt over time shows whether Frazier Lifesciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Frazier Lifesciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.